Avantor® Reiterates Shareholder Value Creation Focus

Group 1 - Avantor, Inc. is set to appoint Emmanuel Ligner as the new CEO starting August 18, 2025, indicating a leadership change aimed at enhancing value creation in the life sciences sector [1][4] - The Board of Directors is actively engaged in overseeing the company's strategy, focusing on growth, margin expansion, and sustained shareholder value [1][3] - Avantor has implemented a $400 million cost transformation program and reduced leverage by nearly $1.5 billion over the past 18 months, demonstrating a commitment to improving financial health [3] Group 2 - Avantor's portfolio is well-positioned to meet the needs of the life sciences and advanced technology industries, supported by a global distribution platform and strong customer relationships [2][6] - The company is prioritizing growth and profitability in its Laboratory Solutions and Bioscience Production segments, reflecting a strategic focus on key operational areas [3][4] - Avantor is enhancing transparency and accountability through business resegmentation and ongoing portfolio optimization efforts [3]